Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS | Zendy

Brendan Rasor | Zendy; Tyler Dickerson | Zendy; Qiuhong Zhao | Zendy; Jonathan E. Brammer | Zendy; Karilyn Larkin | Zendy; Samantha Jaglowski | Zendy; Alice S. Mims | Zendy; Sam Penza | Zendy; Sumithira Vasu | Zendy; Sarah Wall | Zendy; Basem M. William | Zendy; Ayman Saad | Zendy; Julianna Roddy | Zendy; Hannah Choe | Zendy; Marcin Puto | Zendy

Open Access

Comparison of Fixed Dose, Reduced-Intensity Conditioning with Busulfan and Fludarabine to Reduced PK-Guided Busulfan AUC Conditioning in Patients Undergoing Hematopoietic Stem Cell Transplant for AML/MDS

Author(s) -

Brendan Rasor,

Tyler Dickerson,

Qiuhong Zhao,

Jonathan E. Brammer,

Karilyn Larkin,

Samantha Jaglowski,

Alice S. Mims,

Sam Penza,

Sumithira Vasu,

Sarah Wall,

Basem M. William,

Ayman Saad,

Julianna Roddy,

Hannah Choe,

Marcin Puto

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.709

Subject(s) - busulfan , medicine , hematopoietic stem cell transplantation , oncology , adverse effect , fludarabine , regimen , myelodysplastic syndromes , transplantation , gastroenterology , surgery , chemotherapy , cyclophosphamide , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research